Reply to: "Hyperhomocysteinemia predicts liver-related clinical outcomes in the general population".

Tripathi, Madhulika; Singh, Brijesh Kumar; Yen, Paul M

Tripathi, Madhulika; Singh, Brijesh Kumar; Yen, Paul M.

Afiliação

Tripathi M; Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore. Electronic address: madhulika.tripathi@duke-nus.edu.sg.
Singh BK; Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore.
Yen PM; Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore; Duke Molecular Physiology Institute, Duke University School of Medicine, 300 N Duke St, Durham, NC 27701, USA; Endocrinology, Diabetes, and Metabolism Division, Duke University School of Medicine, 300 N Duke St, Durham, NC 27701, USA. Electronic address: paul.yen@duke-nus.edu.sg.

J Hepatol ; 78(5): e174-e175, 2023 05.

Article em En | MEDLINE | ID: mdl-36736736

Assuntos

Hiper-Homocisteinemia; Humanos; Hiper-Homocisteinemia/complicações; Fígado

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiper-Homocisteinemia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Hepatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google